MedRise Shelf Prep

Anticoagulants vs Antiplatelets vs Thrombolytics

Mechanisms, when to use each class, and the exceptions Step 2 CK and the NBME shelf love to test.

1. Medication Classes Overview

ClassPrimary actionExample drugs
AnticoagulantsInhibit coagulation factors (clotting cascade)Heparin, warfarin, DOACs (e.g., apixaban)
AntiplateletsInhibit platelet aggregationAspirin, clopidogrel, ticagrelor
ThrombolyticsBreak down existing clots (fibrinolysis)Alteplase, tenecteplase
AntithromboticsUmbrella term for anticoagulants and antiplateletsNot a separate drug class

2. Mechanism of Action Comparison

Drug classTargetMechanism
AnticoagulantsClotting factors (e.g., Xa, IIa)Block thrombin generation; prevent fibrin clot formation
AntiplateletsPlatelet receptors and enzymes (e.g., P2Y12, COX-1)Prevent platelet plug formation
ThrombolyticsPlasminogen → plasmin activationLyse existing fibrin clots

3. Clinical Use Cases

ScenarioDrug class of choiceExamples
Atrial fibrillation (stroke prevention)AnticoagulantApixaban, rivaroxaban, dabigatran, warfarin
DVT/PE (treatment and prevention)AnticoagulantHeparin → warfarin, or a DOAC
Acute MIAntiplatelet plus anticoagulantAspirin + P2Y12 inhibitor + heparin
Ischemic stroke within 4.5 hours of onsetThrombolytic, if no contraindicationAlteplase or tenecteplase
Mechanical heart valveAnticoagulant (warfarin only)Warfarin; INR goal depends on valve position and risk (e.g., 2.5–3.5 for a mechanical mitral valve)
PAD, stable CAD, TIA preventionAntiplateletAspirin or clopidogrel
STEMI when timely PCI isn't availableThrombolytic + antiplatelet + anticoagulantFibrinolytic + aspirin + clopidogrel + heparin
After PCI with a stentDual antiplatelet therapy (DAPT)Aspirin + clopidogrel or ticagrelor (typically 6 months for stable CAD, 12 months after ACS)

4. Key Step 2/CK + NBME Tips

  • Anticoagulants = prevent new clots (do not break existing ones).

  • Thrombolytics = used acutely to dissolve thrombi (e.g., ischemic stroke, STEMI without PCI).

  • Antiplatelets = arterial clots (e.g., coronary, cerebral) — platelets matter more in high-flow systems.

  • Anticoagulants = venous clots (DVT/PE) — coagulation cascade driven.

  • Never combine anticoagulants + antiplatelets long term unless absolutely indicated (↑↑ bleeding risk).

  • Thrombolytics are contraindicated in most cases of recent surgery, active bleeding, or hemorrhagic stroke history.

Mnemonic: "PAT-A"

LetterStands forClot typeMemory clue
PPlatelet inhibitorsArterial clotsThink plaque and platelets
AAnticoagulantsVenous clotsThink AFib and DVT
TThrombolyticsClot busting nowTime-sensitive tPA
AAntithromboticsUmbrella term“A” for all-encompassing

Drug Quick Sheet

DrugClassMain usesReversal
HeparinAnticoagulantDVT, PE, ACSProtamine sulfate
WarfarinAnticoagulantAFib, mechanical valvesVitamin K plus 4-factor PCC (FFP if PCC unavailable)
Apixaban, rivaroxabanDOAC (factor Xa inhibitor)AFib, DVT/PEAndexanet alfa or 4-factor PCC
DabigatranDOAC (direct thrombin inhibitor)AFib, DVT/PEIdarucizumab
AspirinAntiplateletACS, stroke preventionNo specific antidote (platelet transfusion in selected bleeding)
ClopidogrelAntiplateletAfter PCI, stroke preventionNo specific antidote
Alteplase (tPA)ThrombolyticIschemic stroke, STEMI, massive PECryoprecipitate; tranexamic acid or aminocaproic acid

Master table: exceptions and nuance

ClassMain mechanismPrimary useWhen to useAvoid or use caution
AnticoagulantsInhibit the coagulation cascade (Xa, IIa)VTE, AFib, mechanical valvesVTE treatment; AFib stroke prevention; mechanical valves (warfarin)Active bleeding, hemorrhagic stroke, recent major surgery or trauma. In end-stage kidney disease most DOACs are avoided; warfarin or apixaban is used
AntiplateletsInhibit platelet aggregation (COX-1, P2Y12)Arterial disease (ACS, stroke, PAD)MI and stroke prevention; DAPT after a stentGI bleeding history (relative), aspirin hypersensitivity; not effective for DVT/PE
ThrombolyticsActivate plasmin to lyse clotsIschemic stroke, STEMI, massive PEStroke within 4.5 hours; STEMI without timely PCI; PE with hypotensionBP above 185/110 that can't be lowered, prior hemorrhagic stroke, recent major surgery, active internal bleeding
AntithromboticsUmbrella termPlatelets plus coagulationAny setting that needs clot preventionNot a specific drug class

NBME/Step-Style Exceptions

1. Atrial Fibrillation

  • Use anticoagulants to prevent embolic stroke.

  • Don’t use aspirin alone unless patient is at low CHA₂DS₂-VASc score (e.g., score = 0).

  • Mechanical heart valve → must use warfarin (NOT DOACs like apixaban).

2. Post-MI

  • Dual antiplatelet therapy (DAPT) (aspirin + clopidogrel/ticagrelor) after PCI.

  • Avoid triple therapy (anticoagulant + 2 antiplatelets) unless compelling indication — increased bleeding risk.

  • If patient is on warfarin for Afib + just got a stent, limit DAPT duration and monitor closely.

3. Ischemic Stroke

  • Thrombolytics (alteplase or tenecteplase) within 4.5 hours of onset if the patient meets criteria.

  • Do NOT give tPA if:

    • BP >185/110

    • INR >1.7

    • Platelets <100k

    • Glucose under 50 mg/dL (correct it, then reassess)

    • Stroke >1/3 of MCA territory on CT

4. DVT/PE

  • Start with heparin, then bridge to warfarin or start DOAC directly.

  • Use caution with DOACs when CrCl is under 30 mL/min: most are avoided in end-stage kidney disease, where warfarin or apixaban is used.

5. Pregnancy

  • Use LMWH (enoxaparin) or UFH (doesn’t cross placenta).

  • Avoid warfarin → teratogenic, esp. in 1st trimester.

  • Avoid DOACs → insufficient safety data in pregnancy.

6. Massive PE with Hypotension

  • Use thrombolytics (alteplase) if:

    • Patient is unstable (shock, hypotension)

  • Do not delay lytics for CT angiogram if clinical signs of massive PE and patient crashing.

Summary: first-line choices and what to avoid

Clinical scenarioFirst-lineAvoid
Nonvalvular AFib (CHA2DS2-VASc 2 or more in men, 3 or more in women)DOAC (e.g., apixaban)Aspirin alone
Mechanical heart valveWarfarin (INR goal set by valve type and position)DOACs
Ischemic stroke within 4.5 hoursAlteplase or tenecteplaseAnticoagulants in the first 24 hours after lysis
DVT/PE (not pregnant)DOAC, or heparin → warfarinAntiplatelets alone (they don't treat venous clots)
STEMI without timely PCIFibrinolytic + antiplatelet + anticoagulantLytics with recent major surgery or active bleeding
After PCIDAPT (aspirin + clopidogrel)Long-term triple therapy with warfarin unless clearly needed
DVT in pregnancyLMWH (enoxaparin)Warfarin, DOACs

Reversal agents

DrugReversal agent
HeparinProtamine sulfate
WarfarinVitamin K plus 4-factor PCC (FFP if PCC unavailable)
Apixaban, rivaroxabanAndexanet alfa or 4-factor PCC
DabigatranIdarucizumab
Alteplase (tPA)Cryoprecipitate; tranexamic acid or aminocaproic acid

Book a free strategy call

Ten minutes to look at your exam date, your scores and what is getting in the way.